Stay updated on ADXS11-001 in High Risk Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the ADXS11-001 in High Risk Cervical Cancer Clinical Trial page.

Latest updates to the ADXS11-001 in High Risk Cervical Cancer Clinical Trial page
- Check4 days agoChange DetectedThe study site location was updated from Taoyuan District, Taiwan, 3331 to Taoyuan, Taiwan, 3331 to clarify the municipality associated with the site.SummaryDifference0.0%

- Check12 days agoChange DetectedThe site’s displayed location text for Chile is adjusted by simplifying/changing the regional naming (“Región de la Araucanía” to “Araucania”) for a specific location entry. The page also updates its displayed software/revision version from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision updated to v3.5.0, and the previous Revision v3.4.3 was removed.SummaryDifference0.0%

- Check62 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check76 days agoChange DetectedResults section now includes primary and secondary outcomes (DFS and OS) and safety data, with results posted in 2023-03-14.SummaryDifference0.0%

- Check83 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

Stay in the know with updates to ADXS11-001 in High Risk Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS11-001 in High Risk Cervical Cancer Clinical Trial page.